当前位置:首页 - 行情中心 - 华纳药厂(688799) - 财务分析 - 现金流量表

华纳药厂

(688799)

  

流通市值:64.04亿  总市值:64.04亿
流通股本:1.34亿   总股本:1.34亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金310,679,596.651,362,698,491.41,000,415,489.13655,607,002.27
  收到的税费返还62,463.281,000,079.7339,575,062.52232,901.61
  收到其他与经营活动有关的现金8,562,493.3434,063,501.2545,618,991.6826,518,671.57
  经营活动现金流入小计319,304,553.271,397,762,072.381,085,609,543.33682,358,575.45
  购买商品、接受劳务支付的现金19,966,850.74203,812,379.43112,386,116.5791,007,867.74
  支付给职工以及为职工支付的现金59,207,513.62187,037,942.28142,526,571.5101,190,699.4
  支付的各项税费40,106,020.17143,824,402.8109,257,322.2280,888,184.56
  支付其他与经营活动有关的现金126,971,151.12562,886,837.21515,131,072.18327,194,821.91
  经营活动现金流出小计246,251,535.651,097,561,561.72879,301,082.47600,281,573.61
  经营活动产生的现金流量净额73,053,017.62300,200,510.66206,308,460.8682,077,001.84
二、投资活动产生的现金流量:
  收回投资收到的现金100,041,273.97627,000,000493,000,000403,000,000
  取得投资收益收到的现金142,293.8818,137,063.942,826,868.392,782,019.76
  处置固定资产、无形资产和其他长期资产收回的现金净额-74,763.89--
  处置子公司及其他营业单位收到的现金净额-5,969,037.05-9,595,803.06-
  投资活动现金流入小计100,183,567.85651,180,864.88486,231,065.33405,782,019.76
  购建固定资产、无形资产和其他长期资产支付的现金188,689,970.43520,318,123.84339,451,639.65214,144,284.44
  投资支付的现金170,000,000733,472,605.56527,943,400339,700,000
  支付其他与投资活动有关的现金-6,564,840.11--
  投资活动现金流出小计358,689,970.431,260,355,569.51867,395,039.65553,844,284.44
  投资活动产生的现金流量净额-258,506,402.58-609,174,704.63-381,163,974.32-148,062,264.68
三、筹资活动产生的现金流量:
  吸收投资收到的现金-14,974,38314,974,3839,974,493
  其中:子公司吸收少数股东投资收到的现金--14,974,3839,974,493
  取得借款收到的现金174,398,227383,995,846.4238,252,260.74121,744,764.52
  筹资活动现金流入小计174,398,227398,970,229.4253,226,643.74131,719,257.52
  分配股利、利润或偿付利息支付的现金3,817,650.1262,964,210.3459,762,262.2557,931,865.76
  筹资活动现金流出小计3,817,650.1262,964,210.3459,762,262.2557,931,865.76
  筹资活动产生的现金流量净额170,580,576.88336,006,019.06193,464,381.4973,787,391.76
四、汇率变动对现金及现金等价物的影响-645,151.4-993,338.01-407,517.58-145,063.05
五、现金及现金等价物净增加额-15,517,959.4826,038,487.0818,201,350.457,657,065.87
  加:期初现金及现金等价物余额201,478,427.66175,439,940.58175,439,940.58175,439,940.58
  期末现金及现金等价物余额185,960,468.18201,478,427.66193,641,291.03183,097,006.45
补充资料:
  净利润-228,098,328.6-62,119,334.13
  资产减值准备-8,833,358.42-1,394,445.07
  固定资产和投资性房地产折旧-67,181,107.74-32,875,639.8
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-67,181,107.74-32,875,639.8
  无形资产摊销-3,869,641.72-3,586,552.5
  长期待摊费用摊销-5,775,744.92-3,050,870.48
  处置固定资产、无形资产和其他长期资产的损失-413.06--
  固定资产报废损失-27,257.84-36,424.9
  财务费用-1,640,703.7--145,063.05
  投资损失--84,456,255.41-3,181,624.95
  递延所得税-1,358,727.34-7,540,844.58
  其中:递延所得税资产减少-1,382,829.87-7,564,947.11
    递延所得税负债增加--24,102.53--24,102.53
  存货的减少-11,073,650.88--3,022,808.28
  经营性应收项目的减少--56,444,183.31--31,175,838.5
  经营性应付项目的增加-60,410,018.76-1,886,707.06
  其他-51,964,641.89--
  现金的期末余额-201,478,427.66-183,097,006.45
  减:现金的期初余额-175,439,940.58-175,439,940.58
  现金及现金等价物的净增加额-26,038,487.08-7,657,065.87
公告日期2026-04-212026-04-212025-10-312025-08-30
审计意见(境内)标准无保留意见
TOP↑